MoonLake Immunotherapeutics Investors Face December 15 Legal Deadline

New York, Saturday, 6 December 2025.
Investors in MoonLake Immunotherapeutics with losses over $100,000 are urged to secure legal counsel by December 15 due to a class action lawsuit alleging misleading statements about drug efficacy.